Cargando…

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients

(1) Background: Recently, influences of antihypertensive treatment on the renin–angiotensin–aldosterone system (RAAS) has gained attention, regarding a possible influence on inflammatory and anti-inflammatory pathways. We aimed to study the effects of newly initiated antihypertensive drugs on angiot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vischer, Annina S., Kuster, Gabriela M., Twerenbold, Raphael, Pfister, Otmar, Zhou, Qian, Villiger, Andrea, Poglitsch, Marko, Krähenbühl, Stephan, Mayr, Michael, Osswald, Stefan, Haschke, Manuel, Burkard, Thilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001814/ https://www.ncbi.nlm.nih.gov/pubmed/33802464 http://dx.doi.org/10.3390/cells10030534

Ejemplares similares

SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
por: Kuster, Gabriela M, et al.
Publicado: (2020)

Prevalence and Characterisation of Severe Left Ventricular Hypertrophy Diagnosed by Echocardiography in Hypertensive Patients
por: Apitz, Anett, et al.
Publicado: (2022)

Smoking prevention in adolescents: a cross-sectional and qualitative evaluation of a newly implemented prevention program in Switzerland
por: Meienberg, Andrea, et al.
Publicado: (2021)

Analyzing 24-Hour Blood Pressure Measurements with a Novel Cuffless Pulse Transit Time Device in Clinical Practice—Does the Software for Heartbeat Detection Matter?
por: Kilian, Leo, et al.
Publicado: (2020)

How Should We Measure and Deal with Office Blood Pressure in 2021?
por: Vischer, Annina S., et al.
Publicado: (2021)

Special Issue: Hypertensive Heart Disease—From Pathophysiology to Therapeutical Challenges
por: Vischer, Annina S., et al.
Publicado: (2022)

Antihypertensive medication and outcome in patients with COVID-19 compared to non-COVID respiratory infections
por: Blum, S, et al.
Publicado: (2021)

Hypertensive Heart Disease: A Narrative Review Series—Part 1: Pathophysiology and Microstructural Changes
por: Nemtsova, Valeriya, et al.
Publicado: (2023)

Hypertensive Heart Disease: A Narrative Review Series—Part 2: Macrostructural and Functional Abnormalities
por: Nemtsova, Valeriya, et al.
Publicado: (2023)

Improved agreement and diagnostic accuracy of a cuffless 24-h blood pressure measurement device in clinical practice
por: Socrates, Thenral, et al.
Publicado: (2021)

How should we measure blood pressure? Implications of the fourth blood pressure measurement in office blood pressure
por: Vischer, Annina S., et al.
Publicado: (2020)

Accuracy of abbreviated protocols for unattended automated office blood pressure measurements, a retrospective study
por: Vischer, Annina S., et al.
Publicado: (2021)

Effect of Cuff Inflation on Blood Pressure, Arousals, Sleep Efficiency, and Desaturations: Sub-Analysis of the VAST Pilot Study
por: Socrates, Thenral, et al.
Publicado: (2023)

A model for early failure prediction of blood pressure measurement devices in a stepped validation approach
por: Vischer, Annina S., et al.
Publicado: (2022)

Reply to Hungerford, S.; Bart, N. Blood-Pressure-Monitoring Smartphone Applications: Ushering in a New Era of Wearable Cardiac Devices? Comment on “Vischer et al. Comparability of a Blood-Pressure-Monitoring Smartphone Application with Conventional Measurements—A Pilot Study. Diagnostics 2022, 12, 749”
por: Vischer, Annina S., et al.
Publicado: (2023)

SUN-LB98 RAAS Triple-A Analysis for the Screening of Primary Aldosteronism
por: Burrello, Jacopo, et al.
Publicado: (2020)

The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension
por: Pawlak-Chomicka, Regina, et al.
Publicado: (2022)

RAAS inhibition and mortality in hypertension
por: Ferrari, Roberto
Publicado: (2013)

The RAAS Goodfellas in Cardiovascular System
por: Caputo, Ilaria, et al.
Publicado: (2023)

Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan
por: Liu, Pang-Hsiang, et al.
Publicado: (2008)

Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea
por: Jeong, Hyoseon, et al.
Publicado: (2017)

Comparability of a Blood-Pressure-Monitoring Smartphone Application with Conventional Measurements—A Pilot Study
por: Vischer, Annina S., et al.
Publicado: (2022)

Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors
por: Reddy, Paidi Ramakrishna, et al.
Publicado: (2021)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study
por: Lampart, Maurin, et al.
Publicado: (2022)

Antifibrotic Roles of RAAS Blockers: Update
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives
por: Khalangot, Mykola, et al.
Publicado: (2023)

The Role of Systolic Blood Pressure Reduction in Diastolic Dysfunction: RAAS Inhibition versus Non-RAAS Blood Pressure Lowering
por: Park, Sung-Ji
Publicado: (2020)

Heavy Ion RAA summary Plots 2022
por: The ATLAS collaboration
Publicado: (2022)

RAAS-Blockade in COVID-19: The Ace of Spades?
por: Agarwal, Krishna A., et al.
Publicado: (2021)

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021)

Development and Application of RAA Nucleic Acid Test Strip Assay and Double RAA Gel Electrophoresis Detection Methods for ASFV and CSFV
por: Wu, Keke, et al.
Publicado: (2022)

Heavy Ion Jet RAA Summary Plots 2023
por: The ATLAS collaboration
Publicado: (2023)

Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease
por: Bernardi, Stella, et al.
Publicado: (2016)

Novel RAAS agonists and antagonists: clinical applications and controversies
por: Romero, Cesar A., et al.
Publicado: (2015)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

RAAS inhibitors do not increase the risk of COVID-19
por: Fernández-Ruiz, Irene
Publicado: (2020)

COVID-19 and RAAS inhibitors: is there a final conclusion?
por: Talebi-Taher, Mahshid, et al.
Publicado: (2021)

RAAS inhibitors in COVID-19: not all are created equal!
por: Kow, Chia Siang, et al.
Publicado: (2023)

Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies
por: Arisido, Maeregu Woldeyes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eabkbt9q2r08pcd9jbg3r2gdha